Cargando…

Chromatography as Method for Analytical Confirmation of Paracetamol in Postmortem Material Together with Psychoactive Substances

INTRODUCTION: Paracetamol (Acetaminophen) in addition to aspirin is the most commonly used analgesic and antipyretic medication by millions of patients worldwide. It is an example that paracetamol as medicine that in the world is provided without a doctor’s prescription, can lead to death. Today par...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biscevic-Tokic, Jasmina, Tokic, Nedim, Ibrahimpasic, Elma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AVICENA, d.o.o., Sarajevo 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639358/ https://www.ncbi.nlm.nih.gov/pubmed/26635443 http://dx.doi.org/10.5455/aim.2015.23.322-325

Ejemplares similares

Pneumonia as the Most Common Lower Respiratory Tract Infection
por: Biscevic-Tokic, Jasmina, et al.
Publicado: (2013)

ANALYTICALLY CONFIRMED PRESENCE OF PSYCHOACTIVE SUBSTANCES, ESPECIALLY NEW PSYCHOACTIVE SUBSTANCES IN A GROUP OF PATIENTS HOSPITALIZED WITH MENTAL AND BEHAVIOURAL DISORDERS DUE TO THE USE OF PSYCHOACTIVE SUBSTANCES DIAGNOSIS
por: Engelgardt, Piotr, et al.
Publicado: (2022)

Recent Trends in Analytical Methods to Determine New Psychoactive Substances in Hair
por: Kyriakou, Chrystalla, et al.
Publicado: (2017)

A comparison between two different dried blood substrates in determination of psychoactive substances in postmortem samples
por: Moretti, Matteo, et al.
Publicado: (2021)

Fatal cases involving new psychoactive substances and trends in analytical techniques
por: Ferrari Júnior, Ettore, et al.
Publicado: (2022)

Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act
por: Craft, Sam, et al.
Publicado: (2022)

In Silico Investigations into the Selectivity of Psychoactive and New Psychoactive Substances in Monoamine Transporters
por: Botha, Michelle J., et al.
Publicado: (2022)

Novel Psychoactive Substances and Behavioral Addictions
por: Martinotti, Giovanni, et al.
Publicado: (2014)

Editorial: Pharmacology of new psychoactive substances
por: Lutfy, K., et al.
Publicado: (2023)

Postmortem Confirmation of Human Rabies Source
por: Oliveira, Rafael, et al.
Publicado: (2006)

Novel Psychoactive Substances: The Razor’s Edge between Therapeutical Potential and Psychoactive Recreational Misuse
por: Correia, Beatriz, et al.
Publicado: (2022)

Identification of the synthetic cannabinoid‐type new psychoactive substance, CH‐PIACA, in seized material
por: Pasin, Daniel, et al.
Publicado: (2022)

Self-reported Subjective Effects of Analytically Confirmed New Psychoactive Substances Consumed by e-Psychonauts: Protocol for a Longitudinal Study Using a New Internet-Based Methodology
por: Grifell, Marc, et al.
Publicado: (2021)

Psychoactive substances and the political ecology of mental distress
por: Aggarwal, Sunil K, et al.
Publicado: (2012)

PSYCHOACTIVE SUBSTANCE USE AMONG MEDICAL STUDENTS
por: Ali, R.V. Zulfikar, et al.
Publicado: (1994)

Banning Psychoactive Substances: A Slippery Slope
Publicado: (2015)

Priapism associated with novel psychoactive substance abuse
por: Jones, Patrick, et al.
Publicado: (2015)

An Expanding World of Novel Psychoactive Substances: Opioids
por: Zawilska, Jolanta B.
Publicado: (2017)

Experimentation with psychoactive substances by public school students
por: de Andrade, Maria Eliane, et al.
Publicado: (2017)

New Psychoactive Substances: A Matter of Time
por: Pantano, Flaminia, et al.
Publicado: (2019)

New psychoactive substances: a review and updates
por: Shafi, Abu, et al.
Publicado: (2020)

Psychoactive Substances Taken with Mephedrone and HCV Infection
por: Ordak, Michal, et al.
Publicado: (2021)

Molecular Insights on New Psychoactive Substances (NPSs)
por: Busardò, Francesco Paolo, et al.
Publicado: (2022)

An Update on Psychoactive Substances: Pharmacology and Toxicology Issues
por: Chiappini, Stefania, et al.
Publicado: (2023)

Genotoxicity Evaluation of The Novel Psychoactive Substance MTTA
por: Lenzi, Monia, et al.
Publicado: (2023)

Deaths from novel psychoactive substances in England, Wales and Northern Ireland: Evaluating the impact of the UK psychoactive substances act 2016
por: Deen, Adrian A, et al.
Publicado: (2021)

A STUDY OF COMORBIDITY IN PSYCHOACTIVE SUBSTANCE DEPENDENCE PATIENTS
por: Kisore, Pankaj, et al.
Publicado: (1994)

Prevalence of psychoactive substance use among youth in Rwanda
por: Kanyoni, Maurice, et al.
Publicado: (2015)

Effect of Different Psychoactive Substances on Serum Biochemical Parameters
por: Sanli, Dilek Beker, et al.
Publicado: (2015)

Novel psychoactive substances: What educators need to know
por: Patterson, ZR, et al.
Publicado: (2016)

Sex and Gender Differences in the Effects of Novel Psychoactive Substances
por: Fattore, Liana, et al.
Publicado: (2020)

Sudanese Medical Students’ Perceptions of Psychoactive Substance Use
por: Ibn Auf, Anas, et al.
Publicado: (2020)

Stress and psychoactive substance use among university professors
por: Vieira, Alcivan Nunes, et al.
Publicado: (2021)

An Update on the Implications of New Psychoactive Substances in Public Health
por: Simão, Ana Y., et al.
Publicado: (2022)

Prevalence of consumption of psychoactive substances among construction workers
por: LARAQUI, OMAR, et al.
Publicado: (2021)

Spirituality and the Use of Psychoactive Substances: The Perspective of Polish Students
por: Chrost, Marzena, et al.
Publicado: (2023)

Psychoactive substance use among medical residents in Tunisia
por: Masmoudi, R., et al.
Publicado: (2022)

Chromium in Postmortem Material
por: Dudek-Adamska, Danuta, et al.
Publicado: (2018)

Exploration of the Use of New Psychoactive Substances by Individuals in Treatment for Substance Misuse in the UK
por: Gittins, Rosalind, et al.
Publicado: (2018)

Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders
por: Dal Farra, Deborah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1rg54m4afcujolno7olndgavi4